Speaker Details

Martina J. Porter, MD, FAAD

Martina J. Porter, MD, FAAD

Beth Israel Deaconess Medical Center & Harvard Medical School

BIOGRAPHY

Martina Porter, MD is the Vice Chair for Research and Academics in the Department of Dermatology at Beth Israel Deaconess Medical Center.  She is also the Director of the dermatology clinical trials unit, CLEARS, and the the Co- Leader of the Pathogens, Immunology, and Inflammation Translational Research Hub at Beth Israel Deaconess Medical Center. She specializes in treating dermatologic conditions, including Hidradenitis Suppurativa, Psoriasis, and Atopic Dermatitis, with biologics and small molecules, and leads both investigator-initiated and industry- sponsored clinical trials in these disease indications. Dr. Porter is also the Chair of the American Academy of Dermatology's Patient Safety and Quality Committee and Assistant Professor of Dermatology at Harvard Medical School.

SESSIONS

S017 The Quality Improvement and Innovation Symposium
Mar 27, 2026 1:00 PM - 4:00 PM Bluebird 2E
S025 JAK Inhibitors: A New Frontier in Dermatology
Mar 28, 2026 9:00 AM - 12:00 PM Bluebird 1A
S034 Late-Breaking Research: Session 2
Mar 28, 2026 1:00 PM - 4:00 PM Bellco Theatre
U071 Advancing HS Diagnosis with Artificial Intelligence: A Multi-Phased Collaborative Approach
Mar 29, 2026 8:00 AM - 9:00 AM Mile High 2A

DISCLOSURES

AbbVie – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Alumis – Consultant(Fees); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Bayer – Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Consultant(Fees); Merck – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Mirador – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Consultant(Fees), Investigator(Grants/Research Funding); Oasis Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sonoma Biotherapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Trifecta Clinical – Consultant(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Zura Bio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);